Dietary and Lifestyle-Centered Approach in Gout Care and Prevention
- PMID: 34196878
- PMCID: PMC9281000
- DOI: 10.1007/s11926-021-01020-y
Dietary and Lifestyle-Centered Approach in Gout Care and Prevention
Abstract
Purpose of review: We aim to provide a comprehensive review of the available literature to inform dietary recommendations for patients with gout and hyperuricemia that have the potential to simultaneously lower serum urate and reduce gout morbidity while addressing gout's cardiometabolic comorbidities holistically.
Recent findings: The global burden of gout is rising worldwide, particularly in developed nations as well as in women. Patients with gout are often recommended to follow a low-purine (i.e., low-protein) diet to avoid purine-loading. However, such an approach may lead to increased consumption of unhealthy carbohydrates and fats, which in turn contributes to metabolic syndrome and subsequently raises serum urate levels and leads to adverse cardiovascular outcomes. On the other hand, several well-established diets for cardiometabolic health, such as the Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets, in combination with weight loss for those who are overweight or obese, also have beneficial effects on relevant gout endpoints. It is important to recognize not only the direct effect of diet on hyperuricemia and gout, but its mediated effect through obesity and insulin resistance. Thus, several preeminent healthy dietary patterns that have proven benefits in cardiometabolic health have the power to holistically address not only gout morbidity but also its associated comorbidities that lead to premature mortality among patients with gout.
Keywords: Cardiovascular disease; Diet; Gout; Hyperuricemia; Metabolic syndrome; Nutrition.
Figures
References
-
- Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Hoy D, Almasi-Hashiani A, et al. Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990–2017: a systematic analysis of the Global Burden of Disease Study 2017. Arthritis Rheumatol. 2020;72(11):1916–27. - PubMed
-
Analysis of the Global Burden of Disease Study which revealed that the burden of gout increased worldwide from 1990 to 2017. New Zealand, Australia, and the USA had the highest age-standardized point prevalence estimates of gout in 2017.
-
- Xia Y, Wu Q, Wang H, Zhang S, Jiang Y, Gong T, et al. Global, regional and national burden of gout, 1990–2017: a systematic analysis of the Global Burden of Disease Study. Rheumatology (Oxford). 2020;59(7):1529–38. - PubMed
-
Analysis of the Global Burden of Disease Study which revealed that the global burden of gout increased worldwide, especially in high sociodemographic index countries. Additionally identified high BMI as the leading risk factor for the buden of gout.
-
- Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ Jr, Crowson CS, Matteson EL, et al. The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. J Rheumatol. 2018;45(4):574–9. - PMC - PubMed
-
A population-based study out of Olmsted County, Minnesota, which reported on the rising incidence of gout, as well as higher comorbidity burden among patients with gout at time of diagnosis.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
